A comparison of the efficacy and safety of buserelin vs danazol in the treatment of endometriosis. Protocol 310 Study Group.

Dawood My, M Y Dawood, W N Spellacy, Spellacy Wn, W. Paul Dmowski, W P Dmowski, R D Gambrell, Gambrell Rd, Greenblatt Rb, R B Greenblatt, Y Girard, A Lemay, Mishell Dr, D R Mishell, M Nagamani, Manubai Nagamani, R J Pepperell, Pepperell Rj
Progress in clinical and biological research · 1990 · vol. 323 , pp. 253–67 · PMID:2106142 · W2413537123
article OA: closed CC0 ⤵ 12 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-06 ⓘ

This study compared the efficacy and safety of buserelin to danazol for treating endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

mesh:D004715endometriosis

MeSH descriptors

Buserelin Danazol Endometriosis Pregnadienes Adult Buserelin Buserelin Climacteric Climacteric Clinical Protocols Danazol Danazol Endometriosis Endometriosis Endometriosis Estradiol Estradiol Female Fertility Fertility

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

Cited by (12)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:12:15.619952+00:00
License: CC0 · commercial use OK